Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Epizyme, Inc. (EPZM)
|
Add to portfolio |
|
|
|
| Price: |
$2.68
| | Metrics |
| OS: |
168.4
|
M
| |
-91
|
% ROE
|
| Market cap: |
$451
|
M
| |
-155
|
% ROIC
|
|
Net cash:
|
$71.1
|
M
| |
$0.42
|
per share
|
|
EV:
|
$380
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($247)
|
M
| |
|
|
|
EBIT
|
($251)
|
M
| |
|
|
| EPS |
($1.73)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 37.4 | 15.8 | 23.8 | 21.7 | 10.0 | 8.0 | 2.6 | 41.4 |
| Revenue growth | 137.5% | -33.8% | 9.7% | 117.0% | 24.9% | 212.8% | -93.8% | -39.5% |
| Cost of goods sold | 275.4 | 241.2 | 200.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | -238.0 | -225.4 | -177.1 | 21.7 | 10.0 | 8.0 | 2.6 | 41.4 |
| Gross margin | -635.9% | -1430.1% | -744.3% | 99.9% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | 0.0 | 0.0 | 0.0 | 44.0 | | | | |
| Research and development | | | | 105.8 | 109.7 | 91.5 | 111.2 | 75.6 |
| General and administrative | 0.0 | 0.0 | 0.0 | | 37.2 | 28.4 | 23.9 | 20.9 |
| EBITA | -248.9 | -234.7 | -163.3 | -128.1 | -136.8 | -111.8 | -132.5 | -55.1 |
| EBITA margin | -665.0% | -1489.3% | -686.3% | -590.3% | -1368.4% | -1396.6% | -5177.7% | -132.9% |
| Amortization of intangibles | 4.2 | 3.0 | | | | | | |
| EBIT | -253.1 | -237.7 | -163.3 | -128.1 | -136.8 | -111.8 | -132.5 | -55.1 |
| EBIT margin | -676.2% | -1508.3% | -686.3% | -590.3% | -1368.4% | -1396.6% | -5177.7% | -132.9% |
| Pre-tax income | -251.1 | -231.6 | -170.2 | -123.6 | -134.6 | -110.2 | -132.4 | -54.9 |
| Income taxes | 0.0 | 0.1 | 0.1 | 0.1 | -0.3 | 0.0 | 0.0 | 0.1 |
| Tax rate | | | | | 0.2% | 0.0% | 0.0% | |
| Net income | -251.1 | -231.7 | -170.3 | -123.6 | -134.3 | -110.2 | -132.4 | -55.0 |
| Net margin | -671.0% | -1470.0% | -715.5% | -569.7% | -1343.1% | -1376.4% | -5170.9% | -132.8% |
| |
| Diluted EPS | ($2.45) | ($2.29) | ($1.89) | ($1.72) | ($2.18) | ($1.93) | ($3.32) | ($1.67) |
| Shares outstanding (diluted) | 102.6 | 101.0 | 89.9 | 71.9 | 61.5 | 57.1 | 39.8 | 33.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|